Tag: Johnson & Johnson

December 26, 2018

5 Top Genetics News Stories of 2018

What caught the attention of readers in the genetics market this year? We've compiled a list of our top genetics...
October 24, 2018

Zymeworks Makes First Dermatology Licensing Deal

This is the first joint antibody discovery and development collaboration for Zymeworks and marks the first dermatology-specific partnership for the...
October 16, 2018

Pharmaceutical Update: Q3 2018 in Review

With Q3 behind us and Q4 already in full swing, the Investing News Network is providing a look at some...
October 16, 2018

Genmab Announces Net Sales of DARZALEX (daratumumab) for Third Quarter of 2018

Genmab (Nasdaq:GEN) announced today that worldwide net sales of DARZALEX (daratumumab) as reported by Johnson & Johnson were USD 498...
September 27, 2018

Geron Cancels Janssen Collaboration, Share Price Drops

Geron and Johnson & Johnson’s subsidiary, Janssen Biotech, have terminated their partnership on development of a drug for two different...
September 19, 2018

9 Glucose Monitoring Device Stocks

Demand for glucose monitoring devices with the most advanced technology is growing as the number of diabetic patients increases. Here...
September 17, 2018

Investing in Glucose Monitoring Devices

Diabetes is one of the 10 top killers around the world, and as the healthcare industry races to accommodate growing demand...